Atabak Mokari

Insider Reports History

Location: 1212 Terra Bella Avenue, Mountain View, CA
Signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for Atabak Mokari.
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Atabak Mokari:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
CORCEPT THERAPEUTICS INC	Chief Financial Officer	Common Stock	14.1K	$1.01M	$71.68	Jun 3, 2025	Direct
CORCEPT THERAPEUTICS INC	Chief Financial Officer	Stock option (right to buy)	140K			Feb 28, 2025	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Atabak Mokari

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
CORT	CORCEPT THERAPEUTICS INC	Jun 2, 2025	3	$18.4K	4	Jun 4, 2025	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Feb 28, 2025	4	-$108	4	Mar 4, 2025	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Dec 2, 2024	3	$3.18K	4	Dec 4, 2024	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Sep 3, 2024	3	$8.66K	4	Sep 5, 2024	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Jun 3, 2024	3	$28.1K	4	Jun 5, 2024	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Mar 1, 2024	3	$890	4	Mar 5, 2024	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Feb 9, 2024	1	$0	4	Feb 13, 2024	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Dec 1, 2023	2	$13.2K	4	Dec 5, 2023	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Sep 1, 2023	2	$13.2K	4	Sep 6, 2023	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Jun 1, 2023	2	$37.9K	4	Jun 5, 2023	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Mar 1, 2023	2	$25K	4	Mar 3, 2023	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Sep 1, 2022	2	$20.6K	4	Sep 6, 2022	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Feb 13, 2022	1	$0	4	Feb 15, 2023	Chief Financial Officer
CORT	CORCEPT THERAPEUTICS INC	Feb 2, 2022	1	$0	4	Feb 11, 2022	Chief Financial Officer